TERESA SEAY: Open Payments
NPI 1528159480 · CHIPLEY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 31 payments from 8 companies in 2025. Trend: 2023 $467 · 2024 $693 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $219 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| PFIZER INC. | 3 | $49 |
| Gilead Sciences, Inc. | 2 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $31 |
| QOL Medical, LLC | 1 | $28 |
| Braintree Laboratories, Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 2 | $12 |
Products named: RINVOQ, SKYRIZI, ENTYVIO, XELJANZ, MAVYRET, ZENPEP, Sucraid, LINZESS.
Industry payments across FL — which companies pay providers there.
